ClinicalTrials.govpublic full text
Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome
irritable bowel syndrome, anandamide, cannabinoid, fatty acid amide hydrolase, gastric, motility, small bowel, sensory, motor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873779
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.